Anschutz Medical Campus

Parsons Receives Innovation Transportation Solutions Award from WTS Colorado

Retrieved on: 
Mittwoch, Mai 8, 2024
Lynx, COA, Water quality, Public, City, Denver Union Station, Safety, Federal Transit Administration, Woman, WTS, NEPA, CDOT, Partnership, PSN, Water, BRT, Colorado Department of Transportation, FTA, Engineering, RTD, County, DRCOG, Anschutz Medical Campus, Regional Transportation District, Parsons Corporation

CHANTILLY, Va., May 08, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE:PSN) announced today that the company’s East Colfax Avenue Bus Rapid Transit (BRT) project received the 2024 Innovation Transportation Solutions Award from the Women in Transportation (WTS) Colorado Chapter.

Key Points: 
  • CHANTILLY, Va., May 08, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE:PSN) announced today that the company’s East Colfax Avenue Bus Rapid Transit (BRT) project received the 2024 Innovation Transportation Solutions Award from the Women in Transportation (WTS) Colorado Chapter.
  • WTS is an international organization dedicated to shaping the future of transportation for the public good through the global advancement of women.
  • Parsons is a Champion Partner and active participant in WTS and currently serves as prime for final design of the East Colfax BRT, in addition to providing preliminary engineering and NEPA review.
  • Through a series of design charettes concurrent with direct outreach to the community, the Parsons team created the design which would become The Lynx.

APEX Orthopedics Investments Launches to Revolutionize Foot and Ankle Orthopedic Industry

Retrieved on: 
Dienstag, Mai 7, 2024
USD, University, Achilles tendon, MD, FRCSC, Foot, Ankle, Health, DPM, Anschutz Medical Campus, Investment, Nursing

AURORA, Colo., May 7, 2024 /PRNewswire/ -- APEX Orthopedics Investments, a groundbreaking asset management company dedicated to fostering innovation in the foot and ankle orthopedic sector, announces its establishment.

Key Points: 
  • AURORA, Colo., May 7, 2024 /PRNewswire/ -- APEX Orthopedics Investments, a groundbreaking asset management company dedicated to fostering innovation in the foot and ankle orthopedic sector, announces its establishment.
  • Led by a team of experts and located in the University of Colorado's Anschutz Medical Campus, APEX Orthopedics Investments is poised to transform orthopedic device development.
  • "Our mission at APEX Orthopedics Investments is to catalyze innovation within the foot and ankle orthopedic industry," stated Chris Banas, CEO and President of APEX Orthopedics Investments.
  • To learn more about APEX Orthopedics Investments and its transformative work, please visit www.APEXortho.net .

AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee

Retrieved on: 
Donnerstag, März 28, 2024
Novartis, Acute lymphoblastic leukemia, Head, LG, Translational research, Urology, Oncology, Drug discovery, Executive, LG Chem, Lung, Anschutz Medical Campus, Committee, SRL Diagnostics, University, Laboratory, Doctor of Philosophy, RWTH Aachen University, Senior, Radiopharmaceutical, European Medicines Agency, ARUP Laboratories, Therapy, Drug development, Pharmacology, Pharmaceutical industry

BOSTON, March 25, 2024 (GLOBE NEWSWIRE) -- AVEO Oncology (“AVEO”), an LG Chem company, today announced the appointment of Edgar E. Braendle, MD, PhD as AVEO Oncology’s new Chief Medical Officer. Dr. Braendle is a life sciences executive with experience spanning from early drug discovery to the launch of small molecules, biologics, radiopharmaceuticals, gene and cell therapies, and medical device development.

Key Points: 
  • BOSTON, March 25, 2024 (GLOBE NEWSWIRE) -- AVEO Oncology (“AVEO”), an LG Chem company, today announced the appointment of Edgar E. Braendle, MD, PhD as AVEO Oncology’s new Chief Medical Officer.
  • “We are delighted to have Dr. Braendle join the AVEO Oncology team particularly at this important juncture as we seek to become a global top 20 oncology leader,” said Michael P. Bailey, President and Chief Executive Officer of AVEO Oncology, an LG Chem company.
  • Today, AVEO Oncology, an LG Chem company, and LG Chem Life Sciences also announced the formation of its Scientific Advisory Committee (“Committee”).
  • The Scientific Advisory Committee is comprised of several leading cancer experts, including:
    Professor and Deputy Chair for Translational Research, Department of Gastrointestinal Medical Oncology
    University of Colorado Cancer Center, Aurora

Global Down Syndrome Foundation Launches Matching “21 for 21” Campaign for World Down Syndrome Day with Support from the Safeway Foundation

Retrieved on: 
Donnerstag, März 14, 2024
Anschutz Medical Campus, Congress, Down syndrome, United, Patient, Research, United Nations, University, Guideline, Prenatal development, Bangladesh Technical Education Board

World Down Syndrome Day was promulgated by the United Nations in 2012 and is celebrated in 190 countries.

Key Points: 
  • World Down Syndrome Day was promulgated by the United Nations in 2012 and is celebrated in 190 countries.
  • To learn more about the Global Down Syndrome Foundation and World Down Syndrome Day, visit www.globaldownsyndrome.org/world-down-syndrome-day-month .
  • The Global Down Syndrome Foundation (GLOBAL) is the largest non-profit in the U.S. working to save lives and dramatically improve health outcomes for people with Down syndrome.
  • GLOBAL’s widely circulated medical publications include GLOBAL Medical Care Guidelines for Adults with Down Syndrome , Prenatal & Newborn Down Syndrome Information , and the award-winning Down Syndrome World™ magazine.

Four New Retailers Coming to 21 Fitzsimons and The Fremont on the Anschutz Medical Campus

Retrieved on: 
Dienstag, März 19, 2024
Commercial Building & Real Estate, Construction & Property, Restaurant, Bar, Wine & Spirits, Specialty, REIT, Retail, Residential Building & Real Estate, Anschutz Medical Campus, Patronage, Siren, City, Sable, Heart, Drink, AIRC, AIR, Amusement park

Apartment Income REIT Corp. (NYSE: AIRC) (“AIR” or “AIR Communities”) is thrilled to announce the arrival of four new retailers at 21 Fitzsimons and The Fremont, two premier apartment communities located at the heart of the Anschutz Medical Campus.

Key Points: 
  • Apartment Income REIT Corp. (NYSE: AIRC) (“AIR” or “AIR Communities”) is thrilled to announce the arrival of four new retailers at 21 Fitzsimons and The Fremont, two premier apartment communities located at the heart of the Anschutz Medical Campus.
  • These exciting additions will offer a diverse range of services, catering to the needs of residents, nearby workers, and the greater community.
  • With a passion for experimentation and a dedication to quality, Milieu Fermentation aims to provide a one-of-a-kind taproom experience.
  • “The Anschutz Medical Campus and Fitzsimons Innovation Community are important economic drivers for the City of Aurora and the State of Colorado.

Celebrating Excellence in Anatomy: AAA Awards Distinguished Members

Retrieved on: 
Donnerstag, Februar 8, 2024
Pennsylvania State University, Harvard Medical School, California University, Cell biology, The Anatomical Record, Developmental Dynamics, Stanford University, North Carolina State University, Boston Children's Hospital, Public health, School, Cell, Conference, Associate, Medical education, Mentorship, McGill University, Human body, Hospital, Biomedical sciences, Pediatrics, Anatomical Sciences Education, Forensic anthropology, Anschutz Medical Campus, Dental school, Student, University, AAA, Genetics, Outline of health sciences, Research, Physiology, City University, Chemical engineering, Arkansas College, Division, Orthopedic surgery, UCSF, Dentistry

ROCKVILLE, Md., Feb. 8, 2024 /PRNewswire/ -- The American Association for Anatomy (AAA) is honored to announce its 2024 awards recipients. Eighteen of the association's 2,455 members have been selected because they advanced AAA's values: community, respect, inclusion, integrity, and discovery. 

Key Points: 
  • ROCKVILLE, Md., Feb. 8, 2024 /PRNewswire/ -- The American Association for Anatomy (AAA) is honored to announce its 2024 awards recipients.
  • Eighteen of the association's 2,455 members have been selected because they advanced AAA's values: community, respect, inclusion, integrity, and discovery.
  • The AAA awards program provides over $650,000 in awards, research grants, and scholarships annually.
  • "Being recognized by my AAA idols, mentors, and peers is a cherished honor, reaffirming my commitment to fostering curiosity, deep understanding, and innovation in anatomy education."

Global Down Syndrome Foundation President & CEO Michelle Sie Whitten to be Inducted into the Denver Business Journal Hall of Fame for Her Transformative Research and Medical Work for Children and Adults with Down Syndrome

Retrieved on: 
Donnerstag, Januar 25, 2024
Jesuits, Network affiliate, Hope, Anschutz Medical Campus, Research, American City Business Journals, Life, Face, CO, Happiness, University, Government, Intellectual, Down syndrome, DBJ, Child, Regis University, Parent, Infinity Park, Denver Health Medical Center, Bangladesh Technical Education Board, Anna, Darkness, Growth

Whitten will be joining 40 accomplished young professionals who will receive this prestigious annual recognition award the night of the event.

Key Points: 
  • Whitten will be joining 40 accomplished young professionals who will receive this prestigious annual recognition award the night of the event.
  • From 1993 to 2004 Whitten worked in the TV industry for cable pioneers Peter Barton, her father, John J. Sie and others.
  • In 2003 Whitten gave birth to her first child, Sophia, who happens to have Down syndrome.
  • From that moment, Whitten has dedicated her life to improving the lives of people with Down syndrome through research, medical care, and government advocacy.

Crnic Institute Awarded Anschutz Acceleration Initiative Grant for Pioneering Research Aimed at Improving the Health of Children with Down Syndrome

Retrieved on: 
Donnerstag, Januar 18, 2024
Assistant professor, Network affiliate, Anschutz Medical Campus, Research, Database, AAI, Congress, Philip Anschutz, Associate professor, Health, Rheumatology, JAK, CO, Anschütz, University, MSCS, Quality of life, Chromosome, NIH, Colorado State University, Doctor of Philosophy, T21, Crnić, Inflammation, Doctor of Psychology, Clinical trial, Anna, Immune system, Pharmaceutical industry

“Receiving this grant is deeply gratifying,” says Dr. Joaquín Espinosa, Professor in Pharmacology and Executive Director of the Crnic Institute.

Key Points: 
  • “Receiving this grant is deeply gratifying,” says Dr. Joaquín Espinosa, Professor in Pharmacology and Executive Director of the Crnic Institute.
  • “Everyone at the Crnic Institute, GLOBAL and all our Affiliates have worked so hard in the last ten years to take our remarkable findings from the Petri dish and parlay that into benefit for people with Down syndrome.
  • Key outstanding questions specific to individuals with Down syndrome will be addressed:
    What are the impacts of interferon hyperactivity during early childhood?
  • From over 165 letters of intent and ultimately 56 full proposals, 9 research projects were funded.

Global Down Syndrome Foundation Raises $2.5 Million and Honors Co-Founder Anna Sie at Their Be Beautiful Be Yourself Fashion Show

Retrieved on: 
Dienstag, November 21, 2023
Denver Nuggets, Down syndrome, ABC, Ambassador, Dumb, Bobby Farrelly, Research, Golf, Intellectual, Cancer, NBC, Beauty, Denver Broncos, Love, NFL, Anschutz Medical Campus, Dumb and Dumber, Matsuhisa, Film industry

DENVER, Nov. 21, 2023 (GLOBE NEWSWIRE) -- On Saturday, November 18, Global Down Syndrome Foundation (GLOBAL) raised $2.5 million at their Be Beautiful Be Yourself Fashion Show , held at the Sheraton Denver Downtown Hotel.

Key Points: 
  • DENVER, Nov. 21, 2023 (GLOBE NEWSWIRE) -- On Saturday, November 18, Global Down Syndrome Foundation (GLOBAL) raised $2.5 million at their Be Beautiful Be Yourself Fashion Show , held at the Sheraton Denver Downtown Hotel.
  • The star-studded evening was dedicated to beloved GLOBAL Co-Founder, Anna Sie, who sadly passed away on September 20 after a long and valiant battle with cancer.
  • Anna made it her life's mission to ensure her granddaughter, Sophia, and all people with Down syndrome have a brighter future.
  • “Tonight, as we gather to celebrate the brilliance and beauty of individuals with Down syndrome, we hold my mother, Anna Sie, in our hearts," said Michelle Sie Whitten, President and CEO.

New VOYAGER PAD Analyses Reinforce Benefit of XARELTO® (rivaroxaban) Plus Aspirin Across High-Risk and Complex Patient Populations with Peripheral Artery Disease (PAD)

Retrieved on: 
Dienstag, November 14, 2023
ICH, Rivaroxaban, Buerger's test, Research, Safety, Johnson & Johnson, Thrombin, Food, PAD, DPI, American Heart Association, AHA, Risk, Amputation, CAD, Patient, ALI, Myocardial infarction, Intracerebral hemorrhage, Coagulation, LER, TIMI, FDA, Medical Affairs Bureau, Division, Janssen Pharmaceuticals, Comorbidity, MACE, Vascular disease, Stroke, Standard of care, University, Bleeding, Aspirin, EGFR, Janssen, Disability, Anschutz Medical Campus, Metabolism, Pharmaceutical industry

TITUSVILLE, N.J., Nov. 14, 2023 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefit of XARELTO® (rivaroxaban [2.5 mg twice daily plus aspirin 100 mg once daily]) over standard of care (aspirin alone). Data from the two analyses demonstrate the role of XARELTO® in treating both high-risk and fragile patients and those with and without comorbid coronary artery diseases (CAD). Results were presented at the American Heart Association's (AHA) 2023 Scientific Sessions, hosted in Philadelphia, Pennsylvania, November 11-13, 2023.

Key Points: 
  • "These analyses reinforce the consistency of the favorable benefit-risk profile of XARELTO® plus aspirin for patients with vascular disease, regardless of comorbidity.
  • In fragile patients treated with XARELTO® plus aspirin, 6.2% of patients experienced a MALE compared to 10.3% of patients treated with placebo.
  • In patients with PAD only, 11% of patients treated with XARELTO® plus aspirin experienced a MACE versus 9.8% of patients treated with placebo.
  • Overall, the safety of XARELTO® plus aspirin in patients with PAD was consistent regardless of CAD with no significant interactions.